Trials / Terminated
TerminatedNCT05645133
QPlus Pediatric Reference Interval
Evaluation of a Pediatric Reference Interval Using QPLUS System
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 93 (actual)
- Sponsor
- HemoSonics LLC · Industry
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Accepted
Summary
Evaluation of coagulation results reported by the Qplus Quantra System to determine pediatric reference range intervals.
Detailed description
Single center observational study of the pediatric patient population (\< 18yrs) with normal coagulation function to determine the reference range interval for the clotting parameters reported by the Quantra QPlus system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Diagnostic Test | Diagnostic device to monitor coagulation properties of a whole blood sample at the point of care |
Timeline
- Start date
- 2023-02-27
- Primary completion
- 2023-06-01
- Completion
- 2023-06-10
- First posted
- 2022-12-09
- Last updated
- 2023-06-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05645133. Inclusion in this directory is not an endorsement.